MGO One Seven LLC Boosts Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

MGO One Seven LLC boosted its position in UnitedHealth Group Incorporated (NYSE:UNH) by 17.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 8,751 shares of the healthcare conglomerate’s stock after acquiring an additional 1,306 shares during the quarter. MGO One Seven LLC’s holdings in UnitedHealth Group were worth $4,427,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Sugarloaf Wealth Management LLC lifted its position in UnitedHealth Group by 17.6% during the fourth quarter. Sugarloaf Wealth Management LLC now owns 7,957 shares of the healthcare conglomerate’s stock valued at $4,025,000 after buying an additional 1,193 shares in the last quarter. Signal Advisors Wealth LLC increased its holdings in UnitedHealth Group by 13.0% in the 4th quarter. Signal Advisors Wealth LLC now owns 9,115 shares of the healthcare conglomerate’s stock valued at $4,611,000 after purchasing an additional 1,051 shares in the last quarter. Waycross Partners LLC lifted its stake in shares of UnitedHealth Group by 2.4% during the fourth quarter. Waycross Partners LLC now owns 27,794 shares of the healthcare conglomerate’s stock worth $14,060,000 after purchasing an additional 658 shares in the last quarter. Czech National Bank grew its stake in shares of UnitedHealth Group by 6.1% in the fourth quarter. Czech National Bank now owns 199,536 shares of the healthcare conglomerate’s stock valued at $100,937,000 after buying an additional 11,426 shares in the last quarter. Finally, Lmcg Investments LLC boosted its holdings in UnitedHealth Group by 11.8% in the 4th quarter. Lmcg Investments LLC now owns 37,974 shares of the healthcare conglomerate’s stock worth $19,210,000 after acquiring an additional 4,022 shares during the period. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Stock Performance

Shares of UNH stock opened at $428.25 on Thursday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a 12-month low of $417.12 and a 12-month high of $630.73. The business has a 50 day simple moving average of $506.92 and a 200 day simple moving average of $537.23. The firm has a market capitalization of $391.73 billion, a price-to-earnings ratio of 27.63, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). The company had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same quarter in the prior year, the company earned $6.91 EPS. On average, equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were issued a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.96%. The ex-dividend date was Monday, March 10th. UnitedHealth Group’s payout ratio is currently 35.18%.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on the stock. Hsbc Global Res downgraded shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research note on Tuesday. Cantor Fitzgerald restated an “overweight” rating and set a $700.00 target price on shares of UnitedHealth Group in a research note on Friday, January 17th. Argus downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Monday. Erste Group Bank raised UnitedHealth Group to a “strong-buy” rating in a research report on Wednesday, April 16th. Finally, Morgan Stanley cut their price target on shares of UnitedHealth Group from $664.00 to $563.00 and set an “overweight” rating on the stock in a report on Tuesday. Three research analysts have rated the stock with a hold rating, nineteen have given a buy rating and three have assigned a strong buy rating to the company. According to data from MarketBeat, UnitedHealth Group presently has an average rating of “Buy” and a consensus price target of $604.67.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.